Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage

Resuscitation

Volumn 70, Issue 1, 2006, Pages 133-144

  Ryan, Kathy L ^a   Cortez, Douglas S ^a   Dick Jr , Edward J ^a   Pusateri, Anthony E ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

Bleeding time; Emergency treatment; Hemorrhage; Intravenous hemostasis; Liver injury; Trauma

Indexed keywords

AMINOCAPROIC ACID; APROTININ; DESMOPRESSIN; HEMOSTATIC AGENT; RINGER LACTATE SOLUTION; TRANEXAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLEEDING TIME; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DRUG EFFICACY; FLUID RESUSCITATION; FOOD AND DRUG ADMINISTRATION; LIVER HEMORRHAGE; LIVER INJURY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TAIL;

6-AMINOCAPROIC ACID; ANIMALS; ANTIFIBRINOLYTIC AGENTS; APROTININ; DEAMINO ARGININE VASOPRESSIN; DISEASE MODELS, ANIMAL; DRUG APPROVAL; DRUG THERAPY, COMBINATION; HEMORRHAGE; HEMOSTATICS; INFUSIONS, INTRAVENOUS; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL ANALYSIS; TAIL; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 33745121481     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2005.11.008     Document Type: Article

References (33)

1. Green D., Wong C.A., and Twardowski P. Efficacy of hemostatic agents in improving surgical hemostasis. Transfus Med Rev 10 (1996) 171-182
2. Kovesi T., and Royston D. Pharmacological approaches to reducing allogeneic blood exposure. Vox Sang 84 (2003) 2-10
3. Mahdy A.M., and Webster N.R. Perioperative systemic haemostatic agents. Br J Anaesth 93 (2004) 842-858
4. Erstad B.L. Systemic hemostatic medications for reducing surgical blood loss. Ann Pharmacother 35 (2001) 925-934
5. Hoffman M. The cellular basis of traumatic bleeding. Mil Med 169 (2004) 5-7 4
6. Sauaia A., Moore F.A., Moore E.E., et al. Epidemiology of trauma deaths: a reassessment. J Trauma 38 (1995) 185-193
7. Bellamy R.F. The causes of death in conventional land warfare: implications for combat casualty care research. Mil Med 149 (1984) 55-62
8. Martinowitz U., Holcomb J.B., Pusateri A.E., et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 50 (2001) 721-729
9. Klemcke H.G., Delgado A.V., Holcomb J.B., et al. Effect of recombinat FVIIa in hypothermic, coagulopathic pigs with liver injuries. J Trauma 59 (2005) 155-161
10. Schreiber M.A., Holcomb J.B., Hedner U., Brundage S.I., Macaitis J.M., and Hoots K. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries. J Trauma 53 (2002) 252-257 discussion 257-9
11. Schreiber M.A., Holcomb J.B., Hedner U., et al. The effect of recombinant factor VIIa on noncoagulopathic pigs with grade V liver injuries. J Am Coll Surg 196 (2003) 691-697
12. Lynn M., Jerokhimov I., Jewelewicz D., et al. Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot study. J Trauma 52 (2002) 703-707
13. Jeroukhimov I., Jewelewicz D., Zaias J., et al. Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury. J Trauma 53 (2002) 1053-1057
14. Sondeen J.L., Pusateri A.E., Hedner U., Yantis L.D., and Holcomb J.B. Recombinant factor VIIa increases the pressure at which rebleeding occurs in porcine uncontrolled aortic hemorrhage model. Shock 22 (2004) 163-168
15. Dutton R.P., McCunn M., Hyder M., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 57 (2004) 709-718 discussion 718-9
16. Martinowitz U., Kenet G., Segal E., et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51 (2001) 431-438 discussion 438-9
17. Ghorashian S., and Hunt B.J. "Off-license" use of recombinant activated factor VII. Blood Rev 18 (2004) 245-259
18. O'Leary D.S., Johnson J.M., and Taylor W.F. Mode of neural control mediating rat tail vasodilation during heating. J Appl Physiol 59 (1985) 1533-1538
19. Matsuoka T., Hildreth J., and Wisner D.H. Liver injury as a model of uncontrolled hemorrhagic shock: resuscitation with different hypertonic regimens. J Trauma 39 (1995) 674-680
20. Holcomb J.B., McClain J.M., Pusateri A.E., et al. Fibrin sealant foam sprayed directly on liver injuries decreases blood loss in resuscitated rats. J Trauma 49 (2000) 246-250
21. Klemcke HG. Evaluation of FloSeal as a potential intracavitary hemostatic agent. J Trauma, in press.
22. Herbert J.M., Bernat A., and Maffrand J.P. Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat. Thromb Res 71 (1993) 433-441
23. Elg M., Carlsson S., and Gustafsson D. Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits. Thromb Res 101 (2001) 159-170
24. Butler K.D., Dolan S.L., Talbot M.D., and Wallis R.B. Factor VIII and DDAVP reverse the effect of recombinant desulphatohirudin (CGP 39393) on bleeding in the rat. Blood Coagul Fibrinolysis 4 (1993) 459-464
25. Iomhair M.M., and Lavelle S.M. Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals. Thromb Res 82 (1996) 479-483
26. O'Brien J.G., Battistini B., Zaharia F., Plante G.E., and Sirois P. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats. Inflammation 24 (2000) 411-429
27. Mannucci P.M. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 90 (1997) 2515-2521
28. Tomasiak M.M., Stelmach H., Bodzenta-Lukaszyk A., and Tomasiak M. Involvement of Na+/H+ exchanger in desmopressin-induced platelet procoagulant response. Acta Biochim Pol 51 (2004) 773-788
29. Araki H., and Lefer A.M. Protective actions of aprotinin in acute traumatic shock. Arch Int Pharmacodyn Ther 241 (1979) 316-323
30. Thomae K.R., Mason D.L., and Rock Jr. W.A. Randomized blinded study of aprotinin infusion for liver crush injuries in the pig model. Am Surg 63 (1997) 113-120
31. Paran H., Gutman M., and Mayo A. The effect of aprotinin in a model of uncontrolled hemorrhagic shock. Am J Surg 190 (2005) 463-466
32. Tsai H.M., Sussman I.I., Nagel R.L., and Kaul D.K. Desmopressin induces adhesion of normal human erythrocytes to the endothelial surface of a perfused microvascular preparation. Blood 75 (1990) 261-265
33. Cattaneo M., Tenconi P.M., Alberca I., Garcia V.V., and Mannucci P.M. Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis. Thromb Haemost 64 (1990) 358-360